Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06026098
Other study ID # 23-1262
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2024
Est. completion date August 2024

Study information

Verified date April 2024
Source UNC Lineberger Comprehensive Cancer Center
Contact Shivani Sud
Phone 984-987-1072
Email shivani.sud@unchealth.unc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to explore cognitive burden perceptions among physicians in relation to case report writing. Furthermore, this study evaluates the use of artificial intelligence (AI) assistance as a tool to reduce cognitive burden among providers preparing and submitting case reports. If an AI-tool is helpful in this setting, it may potentially help increase reporting of rare medical events and thereby improve the evidence base for care of these patient populations. This study will occur at a single time point which is expected to last approximately 2 hours. This session will include reviewing two rare tumor cases and then writing a clinical vignette with and without AI assistance.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. The subject is a physician, medical student, or postdoctoral student. Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Artificial Intelligence
Participants will use the Artificial Intelligence assistance tool for case reports.

Locations

Country Name City State
United States Lineberger Comprehensive Cancer Center Chapel Hill North Carolina

Sponsors (1)

Lead Sponsor Collaborator
UNC Lineberger Comprehensive Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjective Cognitive workload (CWL) Subjective Cognitive workload (CWL) will be measured while interviews using The National Aeronautics and Space Administration task load (NASA TLX) index is a tool for measuring and conducting a subjective mental workload (MWL) assessment.
The NASA-TLX is a subjective measure of CWL and is used across many disciplines. The NASA-TLX considers six dimensions-Mental, Physical, and Temporal Demands, Frustration, Effort, and Performance. NASA-TLX scores =55 have been associated with reduced performance in numerous settings. NASA-TLX is considered to be the most used subjective measure of CWL. The validated two-stage process with participants performing 15 separate pair-wise comparisons between 6 dimensions of NASA-TLX will be used. A workload score will be marked from low and high for each dimension.
Score values from 0 -100. The Interpretation Score of NASA TLX for Low 0-9, Medium 10-29, Somewhat high 30-49, High 50-79, and Very high 80-100
Baseline to 2 hours
Primary Perceived cognitive load The perceived cognitive load will be measured using System Usability Scale (SUS).
SUS is a validated post-test questionnaire that measures user satisfaction. Further, studies confirm that SUS is predictive of the impacts of changes to the user interface on usability when multiple changes to a single product were made over a large number of iterations.
SUS is composed of 10 questions- five positive and five negative statements, each having a five-point scale that ranges from strongly disagree to strongly agree. SUS provides a score (range, 0-100) based on the participant's rating of 10 statements regarding usability with higher scores indicating greater satisfaction with usability.
Baseline to 2 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05839405 - Food Allergy in the Brain
Completed NCT04118985 - Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease N/A
Completed NCT04873804 - The Effect of Transcranial Direct Stimulation on Cognitive Functions of Healthy Adults N/A
Completed NCT03736577 - Psychotropic Drug Use in the Elderly Living in Nursing Homes and the Influence of a Structured Drug Review N/A
Completed NCT03624621 - Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM) N/A
Active, not recruiting NCT03469089 - Touchscreen-based Cognitive Tests in Healthy Volunteers Phase 1
Completed NCT03227653 - Neuropsychiatric Side Effects of Efavirenz in Children Living With HIV
Completed NCT04809974 - Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID) Phase 4
Completed NCT03232697 - French Language Validation of the 5-minutes Montreal Cognitive Assessment (MoCA) N/A
Completed NCT04246736 - A Proactive Intervention Promoting Strategies for Sleep and Recovery in Nurses N/A
Not yet recruiting NCT06073886 - Personalized Brain Stimulation to Treat Chronic Concussive Symptoms Phase 2
Recruiting NCT06066619 - Can Cranberry Juice Enhance the Cognition Accuracy and Alleviate Negative Mental Consequences During Multitasking? N/A
Recruiting NCT05400512 - Cognitive Enhancement in Depression (The COG-D Study) N/A
Active, not recruiting NCT05793736 - Prevention of Long Covid Syndrome N/A
Recruiting NCT05162651 - Effect of Extended Cannabis Abstinence on PTSD Symptoms N/A
Withdrawn NCT04423471 - Neuroinflammation, Affective and Cognitive Symptoms in Major Depression and Psoriasis
Completed NCT03246269 - Normative Values for the German Version of the Montreal Cognitive Assessment (MoCA)
Not yet recruiting NCT03353337 - A Study of Aerobic Exercise for Patients With Bipolar Disorder N/A
Completed NCT04499560 - The Effects of a Nutrition Supplement on Health Related Quality of Life N/A
Recruiting NCT04033510 - Acute Cognitive Changes During Atrial Fibrillation Episodes (AFCOG)